|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Costs and expenses: | |||||
| Cost of products sold, excluding depreciation and amortization | |||||
| Depreciation and amortization | |||||
| Selling, general, administrative, research and development | |||||
| Goodwill impairment | |||||
| Restructuring costs | |||||
| Other operating charges, net | |||||
| Total costs and expenses | |||||
| Operating income | |||||
| Other (expense) income: | |||||
| Interest expense | |||||
| Other income, net - Note 13 | |||||
| Income before income taxes | |||||
| Income tax provision | |||||
| Net income | |||||
| Net income per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average number of common shares outstanding (in thousands): | |||||
| Basic | |||||
| Diluted | |||||
Loading...